8876:TSERelo Group, Inc. Analysis
Data as of 2026-03-17 - not real-time
¥1,955.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Relo Group’s share price of ¥1,955 sits comfortably above its 20‑day (¥1,898), 50‑day (¥1,825) and 200‑day (¥1,749) simple moving averages, underscoring a clear bullish trend. The RSI at 66.5 indicates solid momentum while staying clear of overbought territory, and the increasing volume trend supports the price’s upward trajectory toward the nearby resistance at ¥1,960. Although the MACD histogram has turned slightly negative and the MACD line trails its signal, these technical nuances are outweighed by the broader bullish context and strong support at ¥1,807.5.
Fundamentally, the stock appears undervalued with a trailing P/E of 15 versus an industry average of 29, and a forward P/E of 13.6, suggesting pricing headroom. Robust profitability metrics—gross margin near 47% and ROE of 29%—combine with a modest dividend yield of 2.55% and a low payout ratio (~30%), indicating dividend sustainability. While leverage is elevated (debt‑to‑equity ~103%), the company holds substantial cash reserves, and the DCF‑derived fair value of ¥2,939 implies roughly 13% upside potential, reinforcing a favorable risk‑adjusted outlook.
Fundamentally, the stock appears undervalued with a trailing P/E of 15 versus an industry average of 29, and a forward P/E of 13.6, suggesting pricing headroom. Robust profitability metrics—gross margin near 47% and ROE of 29%—combine with a modest dividend yield of 2.55% and a low payout ratio (~30%), indicating dividend sustainability. While leverage is elevated (debt‑to‑equity ~103%), the company holds substantial cash reserves, and the DCF‑derived fair value of ¥2,939 implies roughly 13% upside potential, reinforcing a favorable risk‑adjusted outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term resistance at ¥1,960
- Bearish MACD signal line crossover
- Strong support and rising volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair‑value upside of ~13%
- P/E well below industry average
- Solid ROE and sustainable dividend
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- High ROE and stable earnings growth
- Low beta indicating limited market volatility
- Consistent dividend payout with low payout ratio
Key Metrics & Analysis
Financial Health
Revenue Growth3.70%
Profit Margin14.05%
P/E Ratio15.2
ROE28.94%
ROA6.59%
Debt/Equity102.68
P/B Ratio3.8
Op. Cash Flow¥24.0B
Free Cash Flow¥29.1B
Industry P/E29.4
Technical Analysis
TrendBullish
RSI66.5
Support¥1,807.50
Resistance¥1,960.00
MA 20¥1,898.45
MA 50¥1,824.64
MA 200¥1,748.80
MACDBearish
VolumeIncreasing
Fear & Greed Index81.91
Valuation
Fair Value¥2,938.76
Target Price¥2,212.50
Upside/Downside13.17%
GradeUndervalued
TypeBlend
Dividend Yield2.55%
Risk Assessment
Beta0.24
Volatility16.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.